A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract.

MLA

Ponce, Doris M., et al. “A Phase 2 Study of Interleukin-22 and Systemic Corticosteroids as Initial Treatment for Acute GVHD of the Lower GI Tract.” Blood, vol. 141, no. 12, Mar. 2023, pp. 1389–401. EBSCOhost, https://doi.org/10.1182/blood.2021015111.

APA

Ponce, D. M., Alousi, A. M., Nakamura, R., Slingerland, J., Calafiore, M., Sandhu, K. S., Barker, J. N., Devlin, S., Shia, J., Giralt, S., Perales, M.-A., Moore, G., Fatmi, S., Soto, C., Gomes, A., Giardina, P., Marcello, L., Yan, X., Tang, T., … Hanash, A. M. (2023). A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract. Blood, 141(12), 1389–1401. https://doi.org/10.1182/blood.2021015111

Chicago

Ponce, Doris M, Amin M Alousi, Ryotaro Nakamura, John Slingerland, Marco Calafiore, Karamjeet S Sandhu, Juliet N Barker, et al. 2023. “A Phase 2 Study of Interleukin-22 and Systemic Corticosteroids as Initial Treatment for Acute GVHD of the Lower GI Tract.” Blood 141 (12): 1389–1401. doi:10.1182/blood.2021015111.